改善对出血性中风的抗凝固逆转时间
Braydon Dymm1, Carmelo Graffagnino2, Gabriel Torrealba Acosta3
1Department of Neurology, Charleston Area Medical Center.
概括
实施护理系统的方法减少了口服抗凝剂的脑内出血患者的门到逆转时间. 这种改善中风护理对于管理与这些药物相关的出血风险至关重要.
科学领域:
- 神经学 神经学
- 紧急医疗 紧急医疗
- 卫生系统科学 卫生系统科学
背景情况:
- 口服抗凝药 (OAC) 增加了脑内出血 (ICH) 的风险,导致患者的结果更差.
- 与OAC相关的ICH (OAC-ICH) 涉及更大的中风体积,更多的腹腔内出血和更高的再出血率.
- 指导方针主张快速扭转OAC,但许多系统缺乏优化护理流程.
研究的目的:
- 评估一项综合性中风系统护理改进项目的对OAC-ICH患者门到逆转 (DTR) 时间的影响.
- 评估在多医院网络中实施OAC逆转的标准化方法的可行性.
主要方法:
- 在9个中心和57个区域医院实施了护理系统改进项目.
- 确定和传播了OAC逆转的最佳实践.
- 平均DTR时间在针对60分钟反转时间的机构活动之前和之后进行了比较.
主要成果:
- 这项研究包括两年内889例脑内出血病例,其中73例接受了新出现的逆转剂.
- 基线中位数DTR时间为123分钟.
- 干预后,中位数DTR时间减少了31.7%至84分钟,显示出改善的趋势 (p=0.08).
结论:
- 综合性中风系统的护理方法可以减少急性ICH患者的DTR时间.
- 这一举措证明了改善护理的潜力,尽管缺乏关于逆转目标和协议的最终指导方针.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
Extrinsic and Intrinsic Pathways of Hemostasis
6.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.1K


